Therapeutic efficacy of 166Holmium siloxane in microbrachytherapy of induced glioblastoma in minipig tumor model

Therapeutic efficacy of 166Holmium siloxane in microbrachytherapy of induced glioblastoma in minipig tumor model

Glioblastoma is considered the most common malignant primary tumor of central nervous system. In spite of the current standard and multimodal treatment, the prognosis of glioblastoma is poor. For this reason, new therapeutic approaches need to be developed to improve the survival time of the gliobla...

Full description

Bibliographic Details
Main Authors: Mehrdad Khoshnevis, Richard Brown, Sara Belluco, Ilyes Zahi, Luca Maciocco, Catherine Bonnefont-Rebeix, Elodie Pillet-Michelland, Jonathan Tranel, Thierry Roger, Christophe Nennig, Patrick Oudoire, Lionel Marcon, Olivier Tillement, Cédric Louis, Hélène Gehan, Manuel Bardiès, Maurizio Mariani, Valeria Muzio, Jean-Philippe Meunier, Charlotte Duchemin, Nathalie Michel, Estelle N’Tsiba, Ferid Haddad, Thierry Buronfosse, Claude Carozzo, Frédérique Ponce
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
glioblastoma
U87 cells
minipig
166Ho
microbrachytherapy
animal model
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.923679/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.923679/full

Similar Items